Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome

Description

The purpose of this project is to determine the direct impact of sodium supplementation in preterm infants and to see the overall improvement of their growth and health status. from this study will help us develop a better treatment for in the future.

Conditions

Preterm Birth

Study Overview

Study Details

Study overview

The purpose of this project is to determine the direct impact of sodium supplementation in preterm infants and to see the overall improvement of their growth and health status. from this study will help us develop a better treatment for in the future.

Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome in Preterm Infants

Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome

Condition
Preterm Birth
Intervention / Treatment

-

Contacts and Locations

Milwaukee

Children's wisconsin, Milwaukee, Wisconsin, United States, 53226

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Birthweight \>500 grams and
  • * Gestational age at least 25 0/7weeks but less than 30 weeks.
  • * \<14 days of age at time of randomization
  • * Non-English speaking parents
  • * Major congenital anomalies
  • * grade underlying renal dysfunction (serum creatinine \> 1.0 mg/dL or increase of \>0.3 mg/DL between any two consecutive measurements)
  • * use of diuretics at the time initiation of intervention (approximately 14 days of age) But this is not completely an exclusion-the research can wait 2 days and at the time of 2 week time period of the study we can re check their levels
  • * any structural genitourinary criteria.

Ages Eligible for Study

25 Weeks to 30 Weeks

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Medical College of Wisconsin,

Jeffrey Segar, MD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin

Study Record Dates

2025-12